Management of Coronary Disease in Patients with Advanced Kidney Disease
- 30 March 2020
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 382 (17), 1608-1618
- https://doi.org/10.1056/nejmoa1915925
Abstract
Clinical trials that have assessed the effect of revascularization in patients with stable coronary disease have routinely excluded those with advanced chronic kidney disease.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (U01HL117904, U01HL117905)
This publication has 18 references indexed in Scilit:
- Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practiceAmerican Heart Journal, 2014
- Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary DiseaseThe New England Journal of Medicine, 2012
- Cardiac testing for coronary artery disease in potential kidney transplant recipientsEmergencias, 2011
- A novel technique for ultra‐low contrast administration during angiography or interventionCatheterization and Cardiovascular Interventions, 2009
- Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney DiseaseThe American Journal of Cardiology, 2009
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery DiseaseThe New England Journal of Medicine, 2009
- Contrast-Induced Acute Kidney InjuryJournal of the American College of Cardiology, 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseThe New England Journal of Medicine, 2007
- The exclusion of patients with chronic kidney disease from clinical trials in coronary artery diseaseKidney International, 2006
- Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failureThe Lancet, 1992